Produsele noastre
 Toate produsele
Tractul digestiv şi Metabolism
Preparate antimicrobiene de uz sistemic
Preparate antiparazitare
Organe hematopoietice şi single
Sistemul Cardiovascular
Dermatologia
Sistemul Uro-genital
Sistemul locomotor
Sistemul Nervos
Sistemul Respirator
Preparate planificate
|
 |
Agents Planned for Production
Rostalept
(Neuroleptic agent.)
CONTENT:
Tablets. Tablet contains risperidone 1 mg/ 2 mg / 3 mg / 4 mg.
Solution for oral intake. 1 ml of solution contains risperidone 1 mg.
PHARMACOLOGICAL PROPERTIES:
Risperidone is chemically unrelated to other antipsychotic agents. Risperidone
is an atypical or second-generation antipsychotic agent. Risperidone is a
selective monoaminergic antagonist with high affinity for the serotonin Type 2
(5HT2), dopamine Type 2 (D2), ?1 and ?2 adrenergic, and H1 histaminergic
receptors. Risperidone acts as an antagonist at other receptors, but with lower
potency. Antipsychotic action is attributable to blockage of D2-dopamine
receptors in mesolymbic and mesocortical areas; antiemetic action is due to
blockage of D2-dopamine receptors in trigger zone of emetic center, antipyretic
action is mediated by blockage of D2-dopamine receptors in hypothalamus.
Sedative action is secondary to the adrenergic blockage. Risperidone is
indicated for the treatment of schizophrenia. Risperidon is indicated as
monotherapy or as adjunctive therapy to lithium or valproate for the treatment
of bipolar disorder. Risperidone is used for the management of irritability
associated with autistic disorder.
|
